CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Array Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 22, 2023Formulation Comprising A Mek Inhibitor2
Nov 2, 2022Pharmaceutical Combinations2
Dec 2, 2020Compounds For Use In The Treatment Of Erbb2+ Brain Cancer2
Jul 19, 2017N3 Alkylated Benzimidazole Derivative As Mek Inhibitor1

Top competitors of Array Biopharma

List of top competitors of Array Biopharma based on patent oppositions.